These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8070509)

  • 21. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolone pharmacokinetics in the elderly.
    Schentag JJ; Goss TF
    Am J Med; 1992 Apr; 92(4A):33S-37S. PubMed ID: 1316067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE; Vorob'ev PA; Dvoretskiĭ LI; Izotova GN; Miagkov AV; Shvyreva GS; Iakovlev SV
    Antibiot Khimioter; 1995 Mar; 40(3):47-51. PubMed ID: 7575015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of lomefloxacin on the pharmacokinetics of theophylline.
    LeBel M; Vallée F; St-Laurent M
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1254-6. PubMed ID: 2393286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and safety of lomefloxacin following multiple doses.
    Hunt TL; Adams MA
    Diagn Microbiol Infect Dis; 1989; 12(2):181-7. PubMed ID: 2752716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal tubular secretion and effects of furosemide.
    Odlind B; Beermann B
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ; García I; Pascual A
    Am J Med; 1992 Apr; 92(4A):48S-51S. PubMed ID: 1316071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lomefloxacin on theophylline pharmacokinetics.
    Nix DE; Norman A; Schentag JJ
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1006-8. PubMed ID: 2675751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
    Diao Y; Lu J; Li L; Zhu XD; Ji G; Wang EH
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):247-9. PubMed ID: 8237402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats.
    Kang MJ; Yoon WH; Kim ON; Lee MG
    J Clin Pharm Ther; 1995 Feb; 20(1):13-21. PubMed ID: 7775609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
    Mant TG
    Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential-pulse adsorptive stripping voltammetric determination of the antibacterial lomefloxacin.
    Vílchez JL; Araujo L; Prieto A; Navalón A
    J Pharm Biomed Anal; 2001 Aug; 26(1):23-9. PubMed ID: 11451639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
    Guibert J; Kitzis MD; Acar JF; Masquelier AM; Bellanger B
    Pathol Biol (Paris); 1989 May; 37(5):411-4. PubMed ID: 2506515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Wadworth AN; Goa KL
    Drugs; 1991 Dec; 42(6):1018-60. PubMed ID: 1724637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, open-label, 5-way crossover study to evaluate the pharmacokinetic/pharmacodynamic interaction between furosemide and the non-steroidal anti-inflammatory drugs diclofenac and ibuprofen in healthy volunteers.
    Paterson CA; Jacobs D; Rasmussen S; Youngberg SP; McGuinness N
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):477-90. PubMed ID: 21781648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of the new quinolone antibacterial agents of lomefloxacin and ofloxacin by rat erythrocytes, and its relation to the nicotinic acid transport system.
    Simanjuntak MT; Sato H; Tamai I; Terasaki T; Tsuji A
    J Pharmacobiodyn; 1991 Aug; 14(8):475-81. PubMed ID: 1663548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sparfloxacin pharmacokinetics in healthy volunteers: the influence of acidification and alkalinization.
    Kamberi M; Kotegawa T; Tsutsumi K; Nakamura K; Nakano S
    Eur J Clin Pharmacol; 1998 Oct; 54(8):633-7. PubMed ID: 9860151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.